Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status-Reference-Cited by-同舟云学术

Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status

Published:2020-08 Issue:2 Volume:146 Page:258-261
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Pai Sung-Yun,Thrasher Adrian J.

Funder

The Wellcome Trust

National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference10 articles.

1. The γc family of cytokines: basic biology to therapeutic ramifications;Leonard;Immunity,2019

2. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery;Haddad;Blood,2018

3. Efficacy of gene therapy for X-linked severe combined immunodeficiency;Hacein-Bey-Abina;N Engl J Med,2010

4. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency;Gaspar;Sci Transl Med,2011

5. Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity;Wu;Front Med,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel X-linked mutation in IL2RG associated with early-onset inflammatory bowel disease: a case report of twin brothers;Journal of Medical Case Reports;2023-07-18

2. Correcting inborn errors of immunity: From viral mediated gene addition to gene editing;Seminars in Immunology;2023-03

3. Infectious Complications of Cell-Mediated Immunity Other Than AIDS;Principles and Practice of Pediatric Infectious Diseases;2023

4. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing;Genes;2022-12-13

5. Gene therapy for inborn error of immunity – current status and future perspectives;Current Opinion in Allergy & Clinical Immunology;2022-12-06